Hasil Pencarian - Canrong Lu

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    Ribosomal protein L31 (RPL31) inhibits the proliferation and migration of gastric cancer cells

    Ribosomal protein L31 (RPL31) inhibits the proliferation and migration of gastric cancer cells oleh Fang Wu, Yangyang Liu, Shenglin Hu, Canrong Lu

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    RPL35A is a key promotor involved in the development and progression of gastric cancer

    RPL35A is a key promotor involved in the development and progression of gastric cancer oleh Fang Wu, Dachuan Sun, Yuqian Liao, Kai Shang, Canrong Lu

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Long noncoding RNA regulates tumor cell proliferation and invasion by epithelial–mesenchymal transition in gastric cancer

    Long noncoding RNA regulates tumor cell proliferation and invasion by epithelial–mesenchymal transition in gastric cancer oleh Kecheng Zhang, Canrong Lu, Xiaohui Huang, Jianxin Cui, Jiyang Li, Yunhe Gao, Wenquan Liang, Yi Liu, Yang Sun, Hanxuan Liu, Bo Wei, Lin Chen

    Diterbitkan 2019-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Knockdown of Kremen2 Inhibits Tumor Growth and Migration in Gastric Cancer

    Knockdown of Kremen2 Inhibits Tumor Growth and Migration in Gastric Cancer oleh Beibei Chen, Beibei Chen, Sai-Qi Wang, Sai-Qi Wang, Jinxi Huang, Weifeng Xu, Huifang Lv, Caiyun Nie, Jianzheng Wang, Huichen Zhao, Yingjun Liu, Jitian Li, Canrong Lu, Jianying Zhang, Xiao-Bing Chen, Xiao-Bing Chen

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial

    Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial oleh Xinxin Wang, Canrong Lu, Bo Wei, Shuo Li, Ziyu Li, Yingwei Xue, Yingjiang Ye, Zhongtao Zhang, Yihong Sun, Han Liang, Kai Li, Linghua Zhu, Zhichao Zheng, Yanbing Zhou, Yulong He, Fei Li, Xin Wang, Pin Liang, Hua Huang, Guoli Li, Xian Shen, Jiafu Ji, Yun Tang, Zekuan Xu, Lin Chen, on behalf of RESONANCE study group

    Diterbitkan 2024-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: